Patent US4631284A successfully refreshed from Google Patents.
← Back to Patent Explorer
US4631284A Expired / Lapsed US ⏱️ 0.0 years remaining

Acetaminophen compositions containing low doses of chlorpheniramine maleate, method for preparing same and tablets formed therefrom

Assignee: Mallinckrodt Chemical Inc
•
Filing: 1985-07-16
•
Granted: 1986-12-23
•
Expires: 2005-07-16
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Disclosed are an acetaminophen composition containing a minor amount of a pheniramine maleate, a spray-drying method for preparing the composition and orally administerable analgesic antihistaminic tablets formed from the composition.

Inventors

  • 👤 Anil M. Salpekar
  • 👤 John Johnson

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-31 04:46
CPC Classifications
A; A61; A61K; A61K9/00; A61K9/14; A61K31/00; A61K31/33; A61K31/395; A61K31/435; A61K31/44

Claims Analysis

Total Claims: 26
Claim 1
Independent Claim 259 words
A spray-dried, direct tabletting, free-flowing, particulate pharmaceutical composition having a substantially high amount of acetaminophen and a substantially low amount of a water-soluble pheniramine maleate, and, when prepared in large quantity, being capable of being directly formed into a multiplicity of dosage-form tablets in high-speed tablet-forming operation of pharmaceutical tabletting presses, the pheniramine maleate being present in the composition in such highly uniform distribution throughout that the tablets have such tablet-to-tablet uniformity of the amount of the pheniramine maleate therein that the percent relative standard deviation of said amount is not more than about 3% as determined for a random sample of 10 tablets, the tablets being substantially free of adherence to the press and having high hardness, short disintegration time, and low friability, the composition comprising as components thereof: (A) acetaminophen in a pharmaceutically effective major amount, (B) a water-soluble pheniramine maleate component in a pharmaceutically effective low amount not exceeding about 5.0% based on the total weight of the acetaminophen, (C) a pharmaceutically acceptable binder-disintegrant agent in an amount effective for imparting said hardness, disintegration time and friability, (D) a pharmaceutically acceptable lubricant in an amount at least sufficient to impart effective mold release properties to said tablets, and (E) water in an amount from about 0.5 to about 1.5% based on the total weight of the composition, the composition being the product of spray drying an aqueous liquid slurry comprising an aqueous liquid medium and said components (A), (B), (C) and (D) dispersed substantially uniformly throughout said medium, the pheniramine maleate being dissolved in said medium.
Claim 2
Dependent Claim 259 words
A spray-dried, direct tabletting, free-flowing, particulate pharmaceutical composition having a substantially high amount of acetaminophen and a substantially low amount of a water-soluble pheniramine maleate, and, when prepared in large quantity, being capable of being directly formed into a multiplicity of dosage-form tablets in high-speed tablet-forming operation of pharmaceutical tabletting presses, the pheniramine maleate being present in the composition in such highly uniform distribution throughout that the tablets have such tablet-to-tablet uniformity of the amount of the pheniramine maleate therein that the percent relative standard deviation of said amount is not more than about 3% as determined for a random sample of 10 tablets, the tablets being substantially free of adherence to the press and having high hardness, short disintegration time, and low friability, the composition comprising as components thereof: (A) acetaminophen in a pharmaceutically effective major amount, (B) a water-soluble pheniramine maleate component in a pharmaceutically effective low amount not exceeding about 5.0% based on the total weight of the acetaminophen, (C) a pharmaceutically acceptable binder-disintegrant agent in an amount effective for imparting said hardness, disintegration time and friability, (D) a pharmaceutically acceptable lubricant in an amount at least sufficient to impart effective mold release properties to said tablets, and (E) water in an amount from about 0.5 to about 1.5% based on the total weight of the composition, the composition being the product of spray drying an aqueous liquid slurry comprising an aqueous liquid medium and said components (A), (B), (C) and (D) dispersed substantially uniformly throughout said medium, the pheniramine maleate being dissolved in said medium.
Claim 3
Dependent Claim 23 words
The composition of claim 1 wherein the pheniramine maleate component is selected from pheniramine maleate, chlorpheniramine maleate, d-bromopheniramine maleate and compatible mixtures thereof.
Claim 4
Dependent Claim 13 words
The composition of claim 1 wherein the pheniramine maleate component is chlorpheniramine maleate.
Claim 5
Dependent Claim 13 words
The composition of claim 1 wherein the binder-disintegrant agent is partially gelatinized starch.
Claim 6
Dependent Claim 21 words
The composition of claim 4 wherein the partially gelatinized starch has a Percent Gelatinization of from about 50 to about 75%.
Claim 7
Dependent Claim 32 words
The composition of claim 4 further including a pharmaceuticlly acceptable compressibility-promoting binder as an additional binding agent in an amount effective for increasing the obtainable hardness of tablets formed from the composition.
Claim 8
Dependent Claim 24 words
The composition of claim 6 wherein the additional binding agent is selected from polyvinylpyrrolidone, gelatinized starch which is substantially fully gelatinized and mixtures thereof.
Claim 9
Dependent Claim 12 words
The composition of claim 7 wherein the additional binding agent is pyrrolidone.
Claim 10
Dependent Claim 15 words
The composition of claim 7 wherein the additional binding agent is substantially fully gelatinized starch.
Claim 11
Dependent Claim 33 words
The composition of claim 1 further including a sympathomimetric agent selected from the group consisting of phenylpropanolamine, phenylephrine, pseudoephredine, pharmaceutically acceptable salts thereof, and compatible mixtures of two or more of these agents.
Claim 12
Dependent Claim 21 words
The composition of claim 10 wherein the sympathomimetric agent is selected from phenylpropanolamine hydrochloride, phenylephrine hydrochloride, pseudoephredine hydrochloride and pseudoephredine sulfate.
Claim 13
Dependent Claim 59 words
The composition of claim 1 comprising 100 parts of acetaminophen; from about 0.2 to about 6 parts of a pheniramine maleate component selected from the group consisting of pheniramine maleate, chorpheniramine maleate, d-brompheniramine maleate and mixtures thereof; from about 5 to about 13 parts of a binder-disintegrant agent; and from about 0.1 to about 2 parts of a lubricant.
Claim 14
Dependent Claim 27 words
The composition of claim 12 wherein the binder-disintegrant agent is partially gelatinized starch and further including about 0.5 to about 2 parts of an additional binding agent.
Claim 15
Dependent Claim 12 words
The composition of claim 13 wherein the additional binding agent is polyvinylpyrrolidone.
Claim 16
Independent Claim 356 words
A method for preparing a direct tabletting, free-flowing, particulate pharmaceutical composition having a substantially high amount of acetaminophen and a substantially low amount of a water-soluble pheniramine maleate, and, when prepared in large quantity, being capable of being directly formed into a multiplicity of dosage-form tablets in high-speed tablet-forming operation of pharmaceutical tabletting presses, the pheniramine maleate being present in the composition in such highly uniform distribution throughout that the tablets have such tablet-to-tablet uniformity of the amount of the pheniramine maleate therein that the percent relative standard deviation of said amount is not more than about 3% as determined for a random sample of 10 tablets, the tablets being substantially free of adherence to the press and hivin high hardness, short disintegration time, and low friability, said method comprises: (1) preparing an aqueous liquid slurry comprising an aqueous liquid medium and components dispersed substantially uniformly throughout said medium, said components comprising: (A) finely divided acetaminophen in a pharmaceutically effective major amount, (B) a water-soluble pheniramine maleate component in a pharmaceutically effective low amount not exceeding about 6 parts per 100 parts of the acetaminophen, (C) a pharmaceutically acceptable binder-disintegrant agent in an amount effective for imparting said hardness, disintegration time and friability, and (D) a pharmaceutically acceptable lubricant in an amount at least sufficient to impart effective mold release properties to said tablets, such properties including the tablets being substantially free of adherence to the press, said medium being a solvent for said pheniramine maleate component and said last-mentioned component being dissolved in said medium, the total amount of the dispersed components being such that the slurry is spray-dryable; and (2) while maintaining said components in substantially uniform dispersion spray drying said slurry under spray drying conditions such that the resulting spray dried particulate composition includes water in an amount from about 0.5 to about 1.5% based on the total weight of the composition, said components being distributed throughout the particles of said composition such that at least a portion of said lubricant is dispersed within said particles and at least a portion of the lubricant is disposed on the outer surfaces of said particles.
Claim 17
Independent Claim 356 words
A method for preparing a direct tabletting, free-flowing, particulate pharmaceutical composition having a substantially high amount of acetaminophen and a substantially low amount of a water-soluble pheniramine maleate, and, when prepared in large quantity, being capable of being directly formed into a multiplicity of dosage-form tablets in high-speed tablet-forming operation of pharmaceutical tabletting presses, the pheniramine maleate being present in the composition in such highly uniform distribution throughout that the tablets have such tablet-to-tablet uniformity of the amount of the pheniramine maleate therein that the percent relative standard deviation of said amount is not more than about 3% as determined for a random sample of 10 tablets, the tablets being substantially free of adherence to the press and hivin high hardness, short disintegration time, and low friability, said method comprises: (1) preparing an aqueous liquid slurry comprising an aqueous liquid medium and components dispersed substantially uniformly throughout said medium, said components comprising: (A) finely divided acetaminophen in a pharmaceutically effective major amount, (B) a water-soluble pheniramine maleate component in a pharmaceutically effective low amount not exceeding about 6 parts per 100 parts of the acetaminophen, (C) a pharmaceutically acceptable binder-disintegrant agent in an amount effective for imparting said hardness, disintegration time and friability, and (D) a pharmaceutically acceptable lubricant in an amount at least sufficient to impart effective mold release properties to said tablets, such properties including the tablets being substantially free of adherence to the press, said medium being a solvent for said pheniramine maleate component and said last-mentioned component being dissolved in said medium, the total amount of the dispersed components being such that the slurry is spray-dryable; and (2) while maintaining said components in substantially uniform dispersion spray drying said slurry under spray drying conditions such that the resulting spray dried particulate composition includes water in an amount from about 0.5 to about 1.5% based on the total weight of the composition, said components being distributed throughout the particles of said composition such that at least a portion of said lubricant is dispersed within said particles and at least a portion of the lubricant is disposed on the outer surfaces of said particles.
Claim 18
Dependent Claim 14 words
The method of claim 15 wherein the slurry contains up to about 60% solids.
Claim 19
Dependent Claim 20 words
The method of claim 15 wherein 100% of the finely divided acetaminophen particles will pass through a 200 mesh screen.
Claim 20
Dependent Claim 23 words
The method of claim 15 wherein the pehniramine maleate component is selected from pheniramine maleate, chloropheniramine maleate, d-bromopheniramine maleate and compatible mixtures thereof.
Claim 21
Dependent Claim 13 words
The method of claim 15 wherein the binder-disintegrant agent is partially gelatinized starch.
Claim 22
Dependent Claim 21 words
The method of claim 19 wherein the partially gelatinized starch has a Percent Gelatinization of from about 50 to about 75%.
Claim 23
Dependent Claim 30 words
The method of claim 15 wherein the slurry is formed and maintained under forming and maintaining conditions including sufficiently low shear to avoid increasing said Percent Gelatinization above about 75%.
Claim 24
Dependent Claim 9 words
A tablet formed from the composition of claim 1.
Claim 25
Dependent Claim 9 words
A tablet formed from the composition of claim 12.
Claim 26
Dependent Claim 25 words
A pharmaceutical product comprising a multiplicity of orally administerable tablets prepared by tabletting descrete portions of a large quantity of the composition of claim 1.

References Cited (Backward Citations)

US3362880A Cited
US3314852A Cited
GB1140400A Cited
GB1287431A Cited
GB1390032A Cited
US4264573A Cited
EP0040472A2 Cited
EP0130683A2 Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1989-12-22 1990-06-23 1990-12-23 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1993-12-22 1994-06-23 1994-12-23 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1997-12-22 1998-06-23 1998-12-23 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag